IGF-1 LR3 1mg

OVERVIEW

IGF-1 LR3 NZ is a research-grade peptide Kiwi Peps holds in stock for laboratories across New Zealand, supplied at 1mg per vial. IGF-1 LR3 appears throughout published biochemistry and cell-signalling literature as a compound of interest, and our stock is chosen for consistent molecular weight, stability under lyophilisation, and reproducible chromatography results batch to batch. Each IGF-1 LR3 vial is manufactured using solid-phase peptide synthesis and independently verified against the KP-99 Purity Standard — our 99%+ HPLC-MS release floor — before it is released for sale. Supplied lyophilised, IGF-1 LR3 gives New Zealand researchers a stable, well-characterised growth research peptides compound to work with on the bench.

KEY FEATURES

• High-purity IGF-1 LR3 research peptide
• 1mg lyophilised powder per vial
• HPLC-MS verified purity (98.02%)
• Meets the KP-99 Purity Standard
• Sealed, tamper-evident vial suitable for bench handling
• Bench-Ready Dispatch nationwide across New Zealand

SPECIFICATIONS

Product Name

IGF-1 LR3 1mg

Peptide Grade

Research Grade

Quantity

1mg per vial

Form

Lyophilised powder

Purity

98.02% (HPLC-MS tested)

Appearance

White/off-white lyophilised powder

Storage Conditions

Cool, dry environment; refrigeration recommended for long-term stability

Packaging

Sealed, tamper-evident research vial

WHY KIWI PEPS

Kiwi Peps is a New Zealand-owned research peptide supplier. Every batch of IGF-1 LR3 is checked against the KP-99 Purity Standard and logged in The Batch Book so researchers can pull the matching certificate of analysis before they open the vial. Orders placed before 2pm NZT go out same working day under our Bench-Ready Dispatch promise, via NZ Post CourierPost.